Fresenius | FRE - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Akzo Nobel EUR 1.62B 66M 2025-12
Alcon AG USD 1.58B 80M 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
BASF EUR 2.67B 811M 2025-12
Bayer EUR 6.67B 774M 2025-12
Beiersdorf EUR 1.2B 33M 2025-12
DaVita Healthcare Partners USD 644.24M 32.2M 2026-03
Demant DKK 1.33B 188M 2025-12
E.ON EUR 4.87B 1.83B 2026-03
Essilor EUR 3.54B 758M 2025-12
Fresenius EUR 1.31B 81M 2025-12
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Getinge SEK 2.96B 720M 2024-12
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 1.12B 352M 2025-12
GRIFOLS EUR 801M 242.31M 2025-12
Hikma Pharmaceutical USD 236M 48M 2025-06
Lonza CHF 719M 188M 2025-12
Merck EUR 2.33B 77M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Philips EUR 2.79B 882M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
RWE EUR 7.73B 4.68B 2025-12
Sanofi EUR 7.66B 1.25B 2025-12